International Journal of Medical Microbiology

Editorial – ETOX turned twenty
pp. 451-452(2)
Author: Sebo P.

Pathogenomics of mobile genetic elements of toxigenic bacteria
pp. 453-461(9)
Authors: Hacker J.; Hochhut B.; Middendorf B.; Schneider G.; Buchrieser C.; Gottschalk G.; Dobrindt U.

Host cell modulation by human, animal and plant pathogens
pp. 463-470(8)
Authors: Andersson S.G.&.m.s.p.1.; Kempf V.A.&.m.s.p.1.

In silico identification of novel bacterial ADP-ribosyltransferases
pp. 471-478(8)
Authors: Masignani V.; Balducci E.; Serruto D.; Veggi D.; Aricò B.; Comanducci M.; Pizza M.; Rappuoli R.

The multi-talented bacterial adenylate cyclases
pp. 479-482(4)
Authors: Lory S.; Wolfgang M.; Lee V.; Smith R.

Pathways followed by protein toxins into cells
pp. 483-490(8)
Authors: Sandvig K.; Spilsberg B.; Lauvrak S.U.; Torgersen M.L.; Iversen T-G.; van Deurs B.

Retrograde transport of cholera toxin into the ER of host cells
pp. 491-494(4)
Author: Lencer W.I.

Analysing the action of bacterial toxins in living cells with fluorescence resonance energy transfer (FRET)
pp. 495-503(9)
Author: Majoul I.

The Pasteurella multocida toxin interacts with signalling pathways to perturb cell growth and differentiation
pp. 505-512(8)
Authors: Lax A.J.; Pullinger G.D.; Baldwin M.R.; Harmey D.; Grigoriadis A.E.; Lakey J.H.

E. coli CNF1 toxin: a two-in-one system for host-cell invasion
pp. 513-518(6)
Authors: Landraud L.; Pulcini C.; Gounon P.; Flatau G.; Boquet P.; Lemichez E.

Molecular and cell biology of Legionella pneumophila
pp. 519-527(9)
Authors: Bitar D.M.; Molmeret M.; Abu Kwaik Y.

Superantigens: Structure-function relationships
pp. 529-537(9)
Authors: Baker M.D.; Acharya K.R.

Novel activities of the Helicobacter pylori vacuolating cytotoxin: from epithelial cells towards the immune system
pp. 539-547(9)
Authors: Fischer W.; Gebert B.; Haas R.

Exploitation of host cells by Burkholderia pseudomallei
pp. 549-555(7)
Authors: Stevens M.P.; Galyov E.E.

Clostridium botulinum C2 toxin – New insights into the cellular up-take of the actin-ADP-ribosylating toxin
pp. 557-564(8)
Authors: Aktories K.; Barth H.

Inverted pathogenicity: the use of pathogen-specific molecular mechanisms for prevention or therapy of disease
pp. 565-569(5)
Authors: Rüssmann H.

The adenylate cyclase toxin from Bordetella pertussis – a novel promising vehicle for antigen delivery to dendritic cells
pp. 571-576(6)
Authors: Simsova M.; Sebo P.; Leclerc C.

Recombinant immunotoxins for treating cancer
pp. 577-582(6)
Authors: FitzGerald D.J.; Kreitman R.; Wilson W.; Squires D.; Pastan I.

Bordetella pertussis: from functional genomics to intranasal vaccination
pp. 583-588(6)
Authors: Locht C.; Antoine R.; Raze D.; Mielcarek N.; Hot D.; Lemoine Y.; Mascart F.

The multiple cellular activities of the VacA cytotoxin of Helicobacter pylori
pp. 589-597(9)
Authors: de Bernard M.; Cappon A.; Del Giudice G.; Rappuoli R.; Montecucco C.

Pore worms: Using Caenorhabditis elegans to study how bacterial toxins interact with their target host
pp. 599-607(9)
Authors: Huffman D.L.; Bischof L.J.; Griffitts J.S.; Aroian R.V.

Enterococcal cytolysin: activities and association with other virulence traits in a pathogenicity island
pp. 609-618(10)
Authors: Shankar N.; Coburn P.; Pillar C.; Haas W.; Gilmore M.

In vivo Bacillus anthracis gene expression requires PagR as an intermediate effector of the AtxA signalling cascade
pp. 619-624(6)
Authors: Mignot T.; Couture-Tosi E.; Mesnage S.; Mock M.; Fouet A.